VedPred: Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab
type: Dataset
applicable legislation: oj
access rights: RESTRICTED
creator: Máxima Medical Centre
description: Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab: this retrospective study validated two clinical decision support tools (CDSTs) for predicting effectiveness of vedolizumab in IBD patients with real world data from a Dutch hospital. The CDST predicted clinical, composite and steroid-free remission and adherence after 54 weeks well in patients with ulcerative colitis, but not in patients with Crohn's disease. Therefore, the CDST seems especially useful for choice of therapy in ulcerative colitis.
issued: 2026-08-06T13:40:30.554964
language: en
modified: 2026-08-09T02:19:16.174518
provenance: ProvenanceStatement
publisher: Máxima Medical Centre
contact point: Kind
  fn: Wetenschapsbureau MMC
keyword: Crohn s disease
keyword: clinical decision support tools CDSTs
keyword: colitis ulcerosa
keyword: real world data RWD
keyword: vedolizumab
qualified attribution: Attribution
  agent: Luc Derijks
  had role: principalInvestigator
theme: HEAL